Cannabist Company Holdings (FRA:VW5) EBIT: €-77.3 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VW5 Cannabist Company Holdings Inc FRA:VW5
34 GF Score
Price €0.02
GF Value €15.00
! 3 Warning Signs
View Full Analysis

What is Cannabist Company Holdings EBIT?

Cannabist Company Holdings FRA:VW5 34 EBIT is €-77.3 Mil as of Sep. 2025. GuruFocus rates FRA:VW5 with a GF Score™ of 34/100 and a GF Value™ of €15.00. The stock has 3 warning signs investors should review.

Cannabist Company Holdings's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2025 was €-0.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2025 was €-77.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cannabist Company Holdings's annualized ROC % for the quarter that ended in Sep. 2025 was -11.07%. Cannabist Company Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was -0.30%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cannabist Company Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was -20.34%.

Cannabist Company Holdings  (FRA:VW5) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cannabist Company Holdings's annualized ROC % for the quarter that ended in Sep. 2025 is calculated as:

ROC % (Q: Sep. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Sep. 2025 ))/ count )
=-41 * ( 1 - 0% )/( (383.521 + 357.126)/ 2 )
=-41/370.3235
=-11.07 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=488.848 - 114.733 - ( 13.4 - max(0, 155.199 - 145.793+13.4))
=383.521

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=457.106 - 114.801 - ( 15.132 - max(0, 138.134 - 123.313+15.132))
=357.126

Note: The Operating Income data used here is four times the quarterly (Sep. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Cannabist Company Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Sep. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.844/( ( (288.825 + max(-13.331, 0)) + (278.596 + max(-20.59, 0)) )/ 2 )
=-0.844/( ( 288.825 + 278.596 )/ 2 )
=-0.844/283.7105
=-0.30 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(16.652 + 61.475 + 53.745) - (114.733 + 0 + 30.47)
=-13.331

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(13.147 + 56.941 + 37.663) - (114.801 + 0 + 13.54)
=-20.59

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cannabist Company Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2025 )
=-77.297/380.040
=-20.34 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabist Company Holdings EBIT Related Terms

Cannabist Company Holdings EBIT Historical Data

* Premium members only.

The historical data trend for Cannabist Company Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabist Company Holdings EBIT Chart

Cannabist Company Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial -106.46 -103.28 -71.86 -17.99 -19.15

Cannabist Company Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.06 -37.66 -20.44 -18.99 -0.21

FRA:VW5 vs OWPC, AYURF, PNXP: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabist Company Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabist Company Holdings EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabist Company Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cannabist Company Holdings's EV-to-EBIT falls into.


FRA:VW5
34GF Score
Cannabist Company Holdings Inc FRA:VW5
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cannabist Company Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-77.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €-77.3 Mil mean?
Cannabist Company Holdings (FRA:VW5) has a EBIT of €-77.3 Mil as of Sep. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cannabist Company Holdings.
Is Cannabist Company Holdings' EBIT too high?
Cannabist Company Holdings' current EBIT is €-77.3 Mil. Overall, Cannabist Company Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Cannabist Company Holdings' EBIT compare to OWPC and AYURF?
Cannabist Company Holdings' EBIT of €-77.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cannabist Company Holdings. Cannabist Company Holdings's current EBIT is €-77.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabist Company Holdings stock overvalued right now?
Cannabist Company Holdings (FRA:VW5) has a current EBIT of €-77.3 Mil. The stock's GF Value™ is €15.00, compared to a current price of €0.02 — trading 99.9% below its estimated fair value. The current EBIT is €-77.3 Mil. Cannabist Company Holdings' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Cannabist Company Holdings (FRA:VW5), the current EBIT is €-77.3 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cannabist Company Holdings (FRA:VW5) Overvalued in 2026?

Based on GuruFocus' analysis, Cannabist Company Holdings stock appears to be undervalued. The current stock price of €0.02 is trading 99.9% below its estimated GF Value™ of €15.00.

Key valuation signals for FRA:VW5:

  • EBIT: €-77.3 Mil
  • GF Value™: €15.00 vs. price of €0.02 (99.9% below fair value)
  • GF Score™: 34/100 with 3 warning signs

No single metric tells the full story. See the FRA:VW5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannabist Company Holdings Business Description

Other Exchanges CBSTQ:USA
Address 321 Billerica Road, Suite 204, Chelmsford, MA, USA, 01824
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
34GF Score

Get the complete analysis for FRA:VW5

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.02
Price
€15.00
GF Value